# Reducing Breathlessness With Dronabinol in COPD Patients

> **NCT06473701** · PHASE3 · RECRUITING · sponsor: **Vejle Hospital** · enrollment: 30 (estimated)

## Conditions studied

- COPD
- Breathlessness
- Cannabis

## Interventions

- **DRUG:** Dronabinol 2.5mg Capsule
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06473701
- **Lead sponsor:** Vejle Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-26
- **Primary completion:** 2026-09
- **Final completion:** 2026-10
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-04-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06473701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06473701, "Reducing Breathlessness With Dronabinol in COPD Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06473701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*